Lexaria Bioscience Corp.

LEXX

$13.12

+6.49%

N/A+$0.80

Healthcare

Biotechnology

NASDAQ

Active Trading

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Loading executive datasets...

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Richard C. Christopher	Chief Executive Officer & Director	USD 519,500		1970	Active
John Docherty	Chairman of the Scientific Advisory Board, Chief Scientific Officer, President & Director	USD 430,483		1969	Active
Michael Shankman	Chief Financial Officer	USD 131,217		1961	Active
Vanessa Carle	Head of Legal	—		—	Active
Kristin Hamilton	Director of Operations	—		—	Active
C. Michael Gibson	Chief Medical Advisor & Member of Scientific Advisory Board	—	—	—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of LEXX

RELATIONS

Upstream

InClin, Inc.Unnamed CRO (GLP-1 Studies)BevNologyThird-Party Material/API Suppliers (Unnamed)Third-Party Regulatory Affairs Consultant (Unnamed)Standard Lab Equipment Suppliers (Unnamed)

Downstream

Altria Group, Inc.NYSE:MOPharmaCO (Anonymous Global Pharmaceutical Company)UnconfirmedSulfoSyn LimitedPremier Wellness Science Co., Ltd. (subsidiary of Premier Anti-Aging Co., Ltd.)TYO:4934AnodGen BioceuticalsBevNologyHill Street Beverage Company (now Hill Inc.)TSXV:HILL

Proxies

Catalent, Inc.NYSE:CTLTLonza Group AGSWX:LONNEnteris BioPharma (wholly owned by Spruce Biosciences)UnconfirmedRani Therapeutics Holdings, Inc.NASDAQ:RANI

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer